General MedicationsINJECTIONStandard
RETACRIT
EPOETIN ALFA-EPBX
Standard Dose
10,000UNITS/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview RETACRIT is listed in Drugs@FDA under application 125545 (BLA).
Review priority: STANDARD Marketing status: Prescription Active ingredient EPOETIN ALFA-EPBX Form and strength INJECTABLE;INJECTION - 10,000UNITS/ML Sponsor HOSPIRA INC Submission history Latest submission status date: 2024-06-04 00:00:00.
Structured Monograph
Clinical summary
Approval overview RETACRIT is listed in Drugs@FDA under application 125545 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient EPOETIN ALFA-EPBX Form and strength INJECTABLE;INJECTION - 10,000UNITS/ML Sponsor HOSPIRA INC Submission history Latest submission status date: 2024-06-04 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.